Laryngitis after inhalation of liposomal amikacin
Atsuho Morita, Ho Namkoong, Makoto Hosoya and 1 more
Clinical Case Reports · 2022
doi:10.1002/ccr3.5350 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Abstract A 56‐year‐old woman with pulmonary Mycobacterium avium complex disease was started on inhalation liposomal amikacin. One month later, she developed hoarseness and was diagnosed with laryngitis. The laryngitis healed immediately after treatment discontinuation, and no recurrence occurred even after resuming intermittent inhalation.
Abstract licence: CC BY-NC
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.